2,421
Views
5
CrossRef citations to date
0
Altmetric
Hematology

Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

, , , , &
Pages 902-907 | Received 10 Mar 2020, Accepted 20 Apr 2020, Published online: 20 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Catherine M. Broome. (2023) Complement-directed therapy for cold agglutinin disease: sutimlimab. Expert Review of Hematology 16:7, pages 479-494.
Read now
Emese K. Vágó, Gina Nicholson, Erzsébet Horváth-Puhó, Naushin Hooda, Jon P. Fryzek & Jun Su. (2021) Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Current Medical Research and Opinion 37:10, pages 1829-1835.
Read now

Articles from other publishers (3)

Catherine M. Broome, Naushin Hooda, Jun Su, Xiaohui Jiang, Gina Nicholson, Cara L. Frankenfeld, Melitza Iglesias-Rodriguez, Jon Fryzek & Parija Patel. (2022) Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States. PLOS ONE 17:12, pages e0276617.
Crossref
Huy P PhamAmanda WilsonAyoade AdeyemiGandarvaka MilesKammy KuangPaulo CaritaFlorence Joly. (2022) An observational analysis of disease burden in patients with cold agglutinin disease: Results from a large US electronic health record database. Journal of Managed Care & Specialty Pharmacy 28:12, pages 1419-1428.
Crossref
Alexander Röth, Jon Fryzek, Xiaohui Jiang, Heidi Reichert, Parija Patel, Jun Su, Jaime Morales Arias & Catherine M. Broome. (2021) Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion 62:1, pages 51-59.
Crossref